[HTML][HTML] In search of a cure: the development of therapeutics to alter the progression of spinal muscular atrophy

KS Ojala, EJ Reedich, CJ DiDonato, SD Meriney - Brain Sciences, 2021 - mdpi.com
Until the recent development of disease-modifying therapeutics, spinal muscular atrophy
(SMA) was considered a devastating neuromuscular disease with a poor prognosis for most …

Emerging therapies and challenges in spinal muscular atrophy

MA Farrar, SB Park, S Vucic, KA Carey… - Annals of …, 2017 - Wiley Online Library
Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease with severity
ranging from progressive infantile paralysis and premature death (type I) to limited motor …

[HTML][HTML] New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?

TH Chen - International journal of molecular sciences, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …

Spinal muscular atrophy: a timely review

SJ Kolb, JT Kissel - Archives of neurology, 2011 - jamanetwork.com
Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by loss of
motor neurons in the anterior horn of the spinal cord and resultant weakness. The most …

Spinal muscular atrophy

M Oskoui, P Kaufmann - Neurotherapeutics, 2008 - Springer
Spinal muscular atrophy (SMA) is a potentially devastating and lethal neuromuscular
disease frequently manifesting in infancy and childhood. The discovery of the underlying …

Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next

B Wirth, M Karakaya, MJ Kye… - Annual review of …, 2020 - annualreviews.org
Twenty-five years ago, the underlying genetic cause for one of the most common and
devastating inherited diseases in humans, spinal muscular atrophy (SMA), was identified …

Treatment advances in spinal muscular atrophy

D Bharucha-Goebel, P Kaufmann - Current neurology and neuroscience …, 2017 - Springer
Abstract Purpose of Review Spinal muscular atrophy (SMA) is a genetic disorder of motor
neurons in the anterior horns of the spinal cord and brainstem that results in muscle atrophy …

Spinal muscular atrophy—insights and challenges in the treatment era

E Mercuri, MC Pera, M Scoto, R Finkel… - Nature Reviews …, 2020 - nature.com
Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by
deletion or mutation of SMN1. Four subtypes exist, characterized by different clinical …

Therapeutic approaches for spinal muscular atrophy (SMA)

M Scoto, RS Finkel, E Mercuri, F Muntoni - Gene therapy, 2017 - nature.com
Spinal muscular atrophy is an autosomal recessive neurodegenerative disorder
characterized by progressive muscle wasting and loss of muscle function due to severe …

Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities

L Servais, G Baranello, M Scoto, A Daron… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative
neuromuscular disease that presents primarily in children. Abnormalities in the SMN1 gene …